Related Experiment Video

Updated: Jan 5, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.9K

MicroRNA‑4500 suppresses tumor progression in non‑small cell lung cancer by regulating STAT3

Zhi-Ying Li1, Zi-Zhou Zhang2, Hui Bi1

  • 1Department of Respiratory Medicine, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213000, P.R. China.

Molecular Medicine Reports
|October 23, 2019
PubMed

Insights

MicroRNA-4500 (miR-4500) is reduced in non-small cell lung cancer (NSCLC). This microRNA suppresses NSCLC growth by targeting STAT3, indicating its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • Previous research indicated miR-4500 downregulation in NSCLC, suppressing tumor growth via lin-28 homolog B and NRAS.

Purpose of the Study:

  • To investigate the role of miR-4500 in NSCLC.
  • To identify novel target genes of miR-4500 in NSCLC.
  • To explore the therapeutic potential of miR-4500 in NSCLC.

Main Methods:

  • Quantitative real-time PCR to assess miR-4500 expression in NSCLC tissues and cell lines.
  • Cell proliferation, migration, invasion, and apoptosis assays in NSCLC cell lines (A549, H1975).
  • Luciferase reporter assay to confirm direct targeting of STAT3 by miR-4500.

Main Results:

  • miR-4500 expression was significantly decreased in NSCLC tissues and cells.
  • Overexpression of miR-4500 inhibited NSCLC cell proliferation, migration, and invasion, while promoting apoptosis.
  • STAT3 expression was inversely correlated with miR-4500 levels, and miR-4500 directly targeted STAT3's 3' UTR.
  • Inhibition of miR-4500 partially reversed the tumor-inhibitory effects of STAT3 knockdown.

Conclusions:

  • miR-4500 acts as a tumor suppressor in NSCLC.
  • miR-4500 targets STAT3, contributing to its tumor-suppressive function.
  • miR-4500 represents a potential therapeutic target for NSCLC treatment.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K